.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Teva
UBS
Express Scripts
Chubb
Cantor Fitzgerald
Julphar
Daiichi Sankyo
AstraZeneca
Moodys

Generated: November 18, 2017

DrugPatentWatch Database Preview

PRINZIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Prinzide, and what generic Prinzide alternatives are available?

Prinzide is a drug marketed by Merck and is included in one NDA.

The generic ingredient in PRINZIDE is hydrochlorothiazide; lisinopril. There are thirty-one drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; lisinopril profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck
PRINZIDE
hydrochlorothiazide; lisinopril
TABLET;ORAL019778-003Nov 18, 1993DISCNYesNo► Subscribe► Subscribe► Subscribe
Merck
PRINZIDE
hydrochlorothiazide; lisinopril
TABLET;ORAL019778-001Feb 16, 1989DISCNYesNo► Subscribe► Subscribe► Subscribe
Merck
PRINZIDE
hydrochlorothiazide; lisinopril
TABLET;ORAL019778-002Feb 16, 1989DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PRINZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck
PRINZIDE
hydrochlorothiazide; lisinopril
TABLET;ORAL019778-003Nov 18, 1993► Subscribe► Subscribe
Merck
PRINZIDE
hydrochlorothiazide; lisinopril
TABLET;ORAL019778-001Feb 16, 1989► Subscribe► Subscribe
Merck
PRINZIDE
hydrochlorothiazide; lisinopril
TABLET;ORAL019778-002Feb 16, 1989► Subscribe► Subscribe
Merck
PRINZIDE
hydrochlorothiazide; lisinopril
TABLET;ORAL019778-001Feb 16, 1989► Subscribe► Subscribe
Merck
PRINZIDE
hydrochlorothiazide; lisinopril
TABLET;ORAL019778-003Nov 18, 1993► Subscribe► Subscribe
Merck
PRINZIDE
hydrochlorothiazide; lisinopril
TABLET;ORAL019778-002Feb 16, 1989► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Dow
Healthtrust
Covington
AstraZeneca
Merck
Deloitte
Express Scripts
Harvard Business School
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot